Cargando…

Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center

Detalles Bibliográficos
Autores principales: Liu, Dan, Xu, Zefeng, Zhang, Peihong, Qin, Tiejun, Sun, Xiujuan, Qu, Shiqiang, Pan, Lijuan, Ma, Jiao, Cai, Wenyu, Liu, Jinqin, Wang, Huijun, Sun, Qi, Shi, Zhongxun, Huang, Huijun, Huang, Gang, Gale, Robert Peter, Li, Bing, Rampal, Raajit K., Xiao, Zhijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968909/
https://www.ncbi.nlm.nih.gov/pubmed/34989218
http://dx.doi.org/10.3324/haematol.2021.280080
_version_ 1784679145294266368
author Liu, Dan
Xu, Zefeng
Zhang, Peihong
Qin, Tiejun
Sun, Xiujuan
Qu, Shiqiang
Pan, Lijuan
Ma, Jiao
Cai, Wenyu
Liu, Jinqin
Wang, Huijun
Sun, Qi
Shi, Zhongxun
Huang, Huijun
Huang, Gang
Gale, Robert Peter
Li, Bing
Rampal, Raajit K.
Xiao, Zhijian
author_facet Liu, Dan
Xu, Zefeng
Zhang, Peihong
Qin, Tiejun
Sun, Xiujuan
Qu, Shiqiang
Pan, Lijuan
Ma, Jiao
Cai, Wenyu
Liu, Jinqin
Wang, Huijun
Sun, Qi
Shi, Zhongxun
Huang, Huijun
Huang, Gang
Gale, Robert Peter
Li, Bing
Rampal, Raajit K.
Xiao, Zhijian
author_sort Liu, Dan
collection PubMed
description
format Online
Article
Text
id pubmed-8968909
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-89689092022-04-11 Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center Liu, Dan Xu, Zefeng Zhang, Peihong Qin, Tiejun Sun, Xiujuan Qu, Shiqiang Pan, Lijuan Ma, Jiao Cai, Wenyu Liu, Jinqin Wang, Huijun Sun, Qi Shi, Zhongxun Huang, Huijun Huang, Gang Gale, Robert Peter Li, Bing Rampal, Raajit K. Xiao, Zhijian Haematologica Letters to the Editor Fondazione Ferrata Storti 2022-01-06 /pmc/articles/PMC8968909/ /pubmed/34989218 http://dx.doi.org/10.3324/haematol.2021.280080 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Liu, Dan
Xu, Zefeng
Zhang, Peihong
Qin, Tiejun
Sun, Xiujuan
Qu, Shiqiang
Pan, Lijuan
Ma, Jiao
Cai, Wenyu
Liu, Jinqin
Wang, Huijun
Sun, Qi
Shi, Zhongxun
Huang, Huijun
Huang, Gang
Gale, Robert Peter
Li, Bing
Rampal, Raajit K.
Xiao, Zhijian
Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center
title Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center
title_full Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center
title_fullStr Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center
title_full_unstemmed Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center
title_short Conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center
title_sort conventional interferon-a 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968909/
https://www.ncbi.nlm.nih.gov/pubmed/34989218
http://dx.doi.org/10.3324/haematol.2021.280080
work_keys_str_mv AT liudan conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT xuzefeng conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT zhangpeihong conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT qintiejun conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT sunxiujuan conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT qushiqiang conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT panlijuan conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT majiao conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT caiwenyu conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT liujinqin conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT wanghuijun conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT sunqi conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT shizhongxun conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT huanghuijun conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT huanggang conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT galerobertpeter conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT libing conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT rampalraajitk conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter
AT xiaozhijian conventionalinterferona2bversushydroxyureafornewlydiagnosedpatientswithpolycythemiaverainarealworldsettingaretrospectivestudybasedon286patientsfromasinglecenter